AU2017203070A1 - An Antifungal Formulation - Google Patents

An Antifungal Formulation Download PDF

Info

Publication number
AU2017203070A1
AU2017203070A1 AU2017203070A AU2017203070A AU2017203070A1 AU 2017203070 A1 AU2017203070 A1 AU 2017203070A1 AU 2017203070 A AU2017203070 A AU 2017203070A AU 2017203070 A AU2017203070 A AU 2017203070A AU 2017203070 A1 AU2017203070 A1 AU 2017203070A1
Authority
AU
Australia
Prior art keywords
formulation according
oil
antifungal
amount
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2017203070A
Other versions
AU2017203070B2 (en
Inventor
David Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neat Feat Products Ltd
Original Assignee
Neat Feat Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neat Feat Products Ltd filed Critical Neat Feat Products Ltd
Priority to AU2017203070A priority Critical patent/AU2017203070B2/en
Publication of AU2017203070A1 publication Critical patent/AU2017203070A1/en
Priority to AU2019200904A priority patent/AU2019200904A1/en
Application granted granted Critical
Publication of AU2017203070B2 publication Critical patent/AU2017203070B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Many people suffer from fungal infection of the skin, especially of the feet. The infection may manifest with peeling, redness, itching, burning, blisters and sores. It is known to use various oils for treatment however formulating them into a convenient easy-to-apply watery product presents challenges given that oil and water normally do not mix well. It is an object of a preferred form of the invention to go at least some way towards addressing this by way of an antifungal formulation comprising: " tea tree oil; " neem oil; * glycerol; * surfactant; and " water.

Description

TITLE
An Antifungal Formulation
FIELD OF THE INVENTION A preferred form of the invention relates to an antifungal formulation for human use, preferably although not necessarily for spray-on application.
BACKGROUND
Many people suffer from fungal infection of the skin, especially of the feet. The infection may manifest with peeling, redness, itching, burning, blisters and sores. It is known to use various oils for treatment however formulating them into a convenient easy-to-apply watery product presents challenges given that oil and water normally do not mix well. It is an object of an object of a preferred form of the invention to go at least some way towards addressing this problem.
The term “comprising” if and when used in this document in relation to a combination of features should not be taken to rule out the option of there being other features. It should not be interpreted in a necessarily limiting way.
SUMMARY OF THE INVENTION
According to one aspect of the invention there is provided an antifungal formulation comprising: • tea tree oil; • neem oil; • glycerol; • surfactant; and • water.
Optionally the surfactant (eg a solubiliser) comprises decyl glucoside and/or sorbitan oleate.
Optionally the formulation includes lavender oil and/or ginger oil.
Optionally the formulation includes vinegar, for example apple cider vinegar.
Optionally the formulation includes sodium chloride for facilitating controlling stability and/or viscosity characteristics.
Optionally the formulation is contained within and is able to be delivered as a spray from a spray dispenser.
Optionally the tee tree oil is present in an amount of 4 - 6% by weight of the finished formulation.
Optionally the neem oil is present in an amount of 0.8 - 1.2% by weight of the finished formulation.
Optionally the surfactant is present in an amount of 20 - 30% by weight of the finished formulation.
Optionally the decyl glucoside is present in an amount of 15 - 25% by weight of the finished formulation.
Optionally the sorbitan oleate is present in an amount of 4 - 6% by wt of the finished formulation.
Optionally the lavender oil is present in an amount of 0.8 - 1.2% by wt of the finished formulation.
Optionally the ginger oil is present in an amount of 0.8 - 1.2% by wt of the finished formulation.
Optionally the apple cider vinegar is present in an amount of 1 - 1.5% by weight of the finished formulation.
According to another aspect of the invention there is provided a method of forming a formulation as above, comprising the steps: a) mixing at least the tea tree oil and neem oil with the glycerol to form a sludge; b) mixing in at least the surfactant to form a slurry; and c) mixing in at least the water to form a homogenous spray-on liquid.
Optionally the lavender oil and/or ginger oil is mixed in at step a).
DETAILED DESCRIPTION
In a preferred form of the invention the antifungal formulation uses tee tree oil and neem oil as active ingredients. Lavender oil and ginger oil may be added (it is hypothesised that they may also contribute some antifungal activity). All of the oils are mixed with glycerol as a solvent/solubilser to form a sludge (eg to ‘wet-out’ the oils). Decyl glucoside is then added as a surfactant/solubilser with low energy mixing. Sorbitan oleate is also added as a surfactant/solubilser with further low energy mixing. At this point the combination is in the form of a slurry. A water and sodium chloride mixture is then added with low energy mixing to complete the formulation as a homogenous non-viscous liquid suitable for delivery by way of a hand-held spray dispenser. It can be sprayed onto human skin to treat fungal conditions.
In some embodiments vinegar may be added for pH adjustment after the above otherwise complete mixture has been formed.
In a particularly preferred embodiment of the invention the following ingredients are used in the amounts indicated:
In other embodiments of the invention any or all of the above ingredients may be varied in the amount used, depending on the desired characteristics for the end product.
While decyl glucoside and sorbitan oleate are the preferred surfactants (eg solubilisers), in other embodiments they may be replaced by one or more other suitable surfactants, for example polyglyceryl-6 caprylate, polyglyceryl-4 caprate, polyglyceryl-4 cocoate and/or polyglyceryl-6 ricinoleate.
Peferred embodiments of the invention may be used for treating tinea, athletes’ foot, Jock Itch and/or nail fungal infections
While some preferred forms of the invention have been described by way of example it should be appreciated that modifications and improvements can occur without departing from the scope of the following claims.

Claims (18)

  1. THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:
    1. An antifungal formulation comprising: • tea tree oil; • neem oil; • glycerol; • surfactant; and • water.
  2. 2. An antifungal formulation according to claim 1, wherein the surfactant comprises decyl glucoside and/or sorbitan oleate.
  3. 3. An antifungal formulation according to claim 1 or 2, comprising lavender oil and/or ginger oil.
  4. 4. An antifungal formulation according to claim 1,2 or 3, comprising vinegar.
  5. 5. An antifungal formulation according to claim 1,2 or 3, comprising apple cider vinegar.
  6. 6. An antifungal formulation according to any one of the preceding claims, comprising sodium chloride for controlling desired viscosity and stability characteristics.
  7. 7. An antifungal formulation according to any one of the preceding claims, contained within and able to be delivered as a spray from a spray dispenser.
  8. 8. An antifungal formulation according to any one of the preceding claims, wherein the tee tree oil is present in an amount of 4 - 6% by weight of the finished formulation.
  9. 9. An antifungal formulation according to any one of the preceding claims, wherein the neem oil is present in an amount of 0.8 - 1.2% by weight of the finished formulation.
  10. 10. An antifungal formulation according to any one of the preceding claims, wherein the surfactant is present in an amount of 20 - 30% by weight of the finished formulation.
  11. 11. An antifungal formulation according to any one of the preceding claims, wherein decyl glucoside is present in an amount of 15 - 25% by weight of the finished formulation.
  12. 12. An antifungal formulation according to any one of the preceding claims, wherein sorbitan oleate is present in an amount of 4 - 6% by wt of the finished formulation.
  13. 13. An antifungal formulation according to any one of the preceding claims, wherein lavender oil is present in an amount of 0.8 - 1.2% by wt of the finished formulation.
  14. 14. An antifungal formulation according to any one of the preceding claims, wherein ginger oil is present in an amount of 0.8 - 1.2% by wt of the finished formulation.
  15. 15. An antifungal formulation according to any one of the preceding claims, wherein apple cider vinegar is present in an amount of 1 - 1.5% by weight of the finished formulation.
  16. 16. An antifungal formulation according to claim 1, comprising the following ingredients in or about the amounts indicated:
  17. 17. A method of forming a formulation according to any one of the preceding claims, comprising the steps: a) mixing at least the tea tree oil and neem oil with the glycerol to form a sludge; b) mixing in at least the surfactant to form a slurry; and c) mixing in at least the water to form a homogenous spray-on liquid.
  18. 18. Optionally lavender oil and/or ginger oil is mixed in at step a).
AU2017203070A 2017-05-09 2017-05-09 An Antifungal Formulation Active AU2017203070B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2017203070A AU2017203070B2 (en) 2017-05-09 2017-05-09 An Antifungal Formulation
AU2019200904A AU2019200904A1 (en) 2017-05-09 2019-02-08 An Antifungal Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2017203070A AU2017203070B2 (en) 2017-05-09 2017-05-09 An Antifungal Formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019200904A Division AU2019200904A1 (en) 2017-05-09 2019-02-08 An Antifungal Formulation

Publications (2)

Publication Number Publication Date
AU2017203070A1 true AU2017203070A1 (en) 2018-11-29
AU2017203070B2 AU2017203070B2 (en) 2019-04-04

Family

ID=64332245

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2017203070A Active AU2017203070B2 (en) 2017-05-09 2017-05-09 An Antifungal Formulation
AU2019200904A Abandoned AU2019200904A1 (en) 2017-05-09 2019-02-08 An Antifungal Formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019200904A Abandoned AU2019200904A1 (en) 2017-05-09 2019-02-08 An Antifungal Formulation

Country Status (1)

Country Link
AU (2) AU2017203070B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162304A1 (en) * 2007-12-20 2009-06-25 Dileva Rose Marie Compositions and methods for treating skin conditions in mammals
US20140287064A1 (en) * 2009-04-28 2014-09-25 Karen G. Swenholt Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument
US20160310526A1 (en) * 2008-12-22 2016-10-27 Clearcrescent Technologies, Llc Chlorite-Containing Compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012083341A1 (en) * 2010-12-20 2012-06-28 Le Andrew Tuan Anh Composition for the treatment of skin conditions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162304A1 (en) * 2007-12-20 2009-06-25 Dileva Rose Marie Compositions and methods for treating skin conditions in mammals
US20160310526A1 (en) * 2008-12-22 2016-10-27 Clearcrescent Technologies, Llc Chlorite-Containing Compositions
US20140287064A1 (en) * 2009-04-28 2014-09-25 Karen G. Swenholt Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument

Also Published As

Publication number Publication date
AU2017203070B2 (en) 2019-04-04
AU2019200904A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
JP6505818B2 (en) Plant-derived disinfecting composition, disinfectant and method for producing the same
CN102037966A (en) Eugenol biological pesticide and preparation method thereof
CN105380858B (en) Mosquito repellent bacterio static itching-relieving spray
WO2009129336A2 (en) Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
CN106614636A (en) Sterilization composition containing benziothiazolinone and flutolanil
CN103957901A (en) Skin preparation composition for external use having excellent antiseptic ability
CN101632370B (en) Sterilization combination for preventing and curing downy mildew of fruits and vegetables and aqueous emulsion thereof and preparation method thereof
AU2017203070A1 (en) An Antifungal Formulation
WO2018208173A1 (en) An antifungal formulation
CN108651505A (en) A kind of composition pesticide containing guadipyr and (R)-4-isopropenyl-1-methyl-1-cyclohexene
CN104970053B (en) A kind of mao bamboon extract aqueous emulsion and preparation method thereof
CN106214760A (en) A kind of unguentum preventing and treating gynecological inflammation and preparation method thereof
CN106305764A (en) Environment-friendly emulsion-in-water compounded by flusilazole and prochloraz and preparation method of environment-friendly emulsion-in-water
JP2017105712A (en) Virus diffusion prevention agent
US11696889B2 (en) Botanical antimicrobial composition
CN109362767A (en) A kind of fungicide, preparation method and applications
CN106172401B (en) It is a kind of to eliminate propargite on citrus using the propargite preparation for generating phytotoxicity
CN108849933A (en) A kind of composition pesticide containing (R)-4-isopropenyl-1-methyl-1-cyclohexene and paichongding
CN101518246A (en) Flusilazole-containing aqueous emulsion
US20160120903A1 (en) Topical Relief Cream Formulation for Allergic Reactions to Poison Ivy, Poison Oak, Poison Sumac, Minor Skin Irritations and Insect Bites
CN105638670A (en) Germicidal composition prepared from triflumizole and SYP-Z048
US11419910B1 (en) Treatment of dermatitis and athlete's foot
JP2009221127A (en) Cosmetic
CH710459A1 (en) Mix repellent against ticks.
CN105193726A (en) Pharmaceutical composition for treating leuconychia

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted
NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO GAIN ACCEPTANCE HAS BEEN EXTENDED TO 09 APR 2019

FGA Letters patent sealed or granted (standard patent)